• News
  • Video
  • Prices
  • Research
  • Events
  • Data & Indices
  • More
  • Sponsored
    Sign In
    Sign Up
Loading chart...


About
  • About Us
  • Masthead
  • Careers
  • Blog
  • Investor Relations
Contact
  • Contact Us
  • Accessibility
  • Advertise
  • Media Kit
  • Sitemap
  • System status
Newsletters
  • CoinDesk Headlines
  • Crypto Daybook Americas
  • State of Crypto
  • Crypto for Advisors
  • Crypto Long & Short
News
  • Markets
  • Finance
  • Tech
  • Policy
  • Focus
Videos
  • CoinDesk Daily
  • Editor's Picks
  • Shorts
  • Spotlight
Podcasts
  • CoinDesk Podcast Network
  • Markets Outlook
  • Gen C
Cryptocurrencies
  • Latest crypto prices
  • Trending
  • Bitcoin (BTC)
  • Ethereum (ETH)
  • Hyperliquid (HYPE)
  • XRP
  • Solana (SOL)
Data & Indices
  • Market Data
  • Index Offering
  • API
  • Research Insights
  • Documentation and Governance
Events
  • CoinDesk: Policy & Regulation
  • Webinars
Sponsored
  • Thought Leadership
  • Press Releases
  • Advertise with CoinDesk
Research
  • Research Hub
  • Exchange Benchmark

EthicsPrivacyTerms of UseCookie SettingsDo Not Sell My InfoBug Bounty Program
X icon
© 2026 CoinDesk, Inc.

Disclosure & Polices: CoinDesk is an award-winning media outlet that covers the cryptocurrency industry. Its journalists abide by a strict set of editorial policies. CoinDesk has adopted a set of principles aimed at ensuring the integrity, editorial independence and freedom from bias of its publications. CoinDesk is part of Bullish (NYSE:BLSH), an institutionally focused global digital asset platform that provides market infrastructure and information services. Bullish owns and invests in digital asset businesses and digital assets and CoinDesk employees, including journalists, may receive Bullish equity-based compensation.

CD20$2,143.82CD20 up 0.11 percent0.11%BTC$77,362.32BTC up 0.23 percent0.23%ETH$2,393.63ETH down 0.87 percent0.87%XRP$1.35XRP up 0.14 percent0.14%SOL$99.72SOL up 0.13 percent0.13%
Prices > DVA
DVADVA
$179.55Up 1.94 percent, +$3.411.94%($3.41)
As of today at 12:55 PM ET

Key Stats

Market Cap$11.238B
Volume (24h)187,735
Day's Range$176.43-$179.72
52-Week Range$101.00-$247.49
PE Ratio43.79
EPS4.10
Net Income (FY)$1.08B
Revenue (FY)$13.64B

About DaVita Inc.

DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

Website
davita.com
Industry
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Full-time Employees
78,000
Headquarters
DENVER
IPO Date
Oct 31, 1995
Loading chart...
24 hours5 days1 monthYTD1 yearAll time
Up 1.94 percent1.94%
Up 0.37 percent0.37%
Down 25.22 percent25.22%
Up 57.75 percent57.75%
Up 30.34 percent30.34%
Up 1643.20 percent1643.20%

Similar Stocks

S
S&P 500 ETFSPY
$765.12
Up 0.44 percent0.44%($3.34)
BullishBLSH
$32.61
Down 1.36 percent1.36%($0.45)
Coinbase Global IncCOIN
$174.88
Down 1.10 percent1.10%($1.94)
Circle Internet GroupCRCL
$88.80
Down 0.76 percent0.76%($0.68)

Latest DVA News

Zacks Industry Outlook Highlights DaVita, LifeStance Health, Option Care Health, and Aveanna Healthcare
2 days agoNeutral
(opens in a new tab)

Zacks Industry Outlook Highlights DaVita, LifeStance Health, Option Care Health, and Aveanna Healthcare

6 days agoPositive(opens in a new tab)

Warren Buffett and Greg Abel Quietly Hold a Bigger Percentage of This Company Than Any Other in Berkshire's Portfolio (Hint: It's Not Apple or American Express)

Jul 9, 2026, 6:30 p.m. ETPositive(opens in a new tab)

Everyone Is Watching Greg Abel. But Another Berkshire Hathaway Stock Picker Is Quietly Winning in 2026.

Jun 3, 2026, 12:05 p.m. ETNeutral(opens in a new tab)

1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't

May 6, 2026, 1:35 p.m. ETPositive(opens in a new tab)

S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16% On AI Hype: Stock Market Today

Mar 30, 2026, 1:33 p.m. ETPositive(opens in a new tab)

Heart Risks Go Beyond the Heart: Don’t Forget to Check Blood Sugar and Kidney Health

Mar 17, 2026, 7:00 a.m. ETPositive(opens in a new tab)

R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease